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Emerin plays a crucial role in 
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Alteration of the nuclear Ca2+ transient is an early event in cardiac remodeling. Regulation of the nuclear 
Ca2+ transient is partly independent of the cytosolic Ca2+ transient in cardiomyocytes. One nuclear 
membrane protein, emerin, is encoded by EMD, and an EMD mutation causes Emery-Dreifuss muscular 
dystrophy (EDMD). It remains unclear whether emerin is involved in nuclear Ca2+ homeostasis. The aim 
of this study is to elucidate the role of emerin in rat cardiomyocytes by means of hypertrophic stimuli 
and in EDMD induced pluripotent stem (iPS) cell-derived cardiomyocytes in terms of nuclear structure 
and the Ca2+ transient. The cardiac hypertrophic stimuli increased the nuclear area, decreased nuclear 
invagination, and increased the half-decay time of the nuclear Ca2+ transient in cardiomyocytes. Emd 
knockdown cardiomyocytes showed similar properties after hypertrophic stimuli. The EDMD-iPS cell-
derived cardiomyocytes showed increased nuclear area, decreased nuclear invagination, and increased 
half-decay time of the nuclear Ca2+ transient. An autopsied heart from a patient with EDMD also 
showed increased nuclear area and decreased nuclear invagination. These data suggest that Emerin 
plays a crucial role in nuclear structure and in the nuclear Ca2+ transient. Thus, emerin and the nuclear 
Ca2+ transient are possible therapeutic targets in heart failure and EDMD.
Intracellular Ca2+ plays central roles in physiology and pathophysiology of cardiomyocytes, such as 
excitation-contraction (EC) coupling and secondary messengers1,2. Homeostatic Ca2+ oscillation directly regu-
lates rhythmical cardiomyocyte contractions. During a cardiomyocyte contraction, cardiac myocyte membrane 
depolarization causes the voltage-dependent L-type Ca2+ channel (LTCC) to drive Ca2+ entry into the cyto-
plasm3. The increase in intracellular Ca2+ concentration triggers a greater release of Ca2+ from the sarcoplasmic 
reticulum (SR). The excess Ca2+ binds to the myofilament and induces the subsequent myocyte contraction. 
During cardiomyocyte relaxation, cytoplasmic Ca2+ is exported outside the cell via the sarcolemmal Na+/Ca2+ 
exchanger (NCX) and pumped into SR through the SR Ca2+ ATPase (SERCA). In addition to the role in con-
traction, intracellular Ca2+ has a definitive function as a secondary messenger for various cellular physiologi-
cal processes. The increased Ca2+ level stimulates Ca2+-calmodulin (CaM)-dependent protein phosphatase 2B 
(calcineurin), which activates nuclear factor of activated T cells (NFAT) to drive transcription of several genes4. 
The cytoplasmic Ca2+ signal also activates calmodulin-dependent kinases (CaMKs), which positively regulate 
several transcription factors including myocyte-enhancing factor 2 s (MEF2s) and mediate nuclear translocation 
of chromatin-modifying enzymes including histone deacetylases (HDACs)5,6. There are many signaling pathways 
mediated by cytoplasmic Ca2+ in cardiomyocytes; these pathways are intimately involved in development, phys-
iology, and pathophysiology of the heart. Nonetheless, it is unclear how oscillations in Ca2+ regulate signaling 
pathways, e.g., peak Ca2+, diastolic Ca2+, and micro location7. Among several organelles within cardiomyocytes, 
the nucleus is an exclusive location for transcription and is separated from the cytoplasm by the nuclear envelope. 
Ca2+ oscillation in the nucleus (just as in the cytoplasm) is also observed in cardiomyocytes8. The regulation of 
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the so-called nuclear Ca2+ transient is partly independent of the cytoplasmic Ca2+ transient in cardiomyocytes9. 
The perinuclear microdomains are believed to control the nuclear Ca2+ transient10,11. Moreover, alteration of the 
nuclear Ca2+ transient is an early event in cardiac remodeling12. These data suggest that the nuclear Ca2+ transient 
is finely regulated and plays an important role in cardiac pathophysiology, but it remains largely unclear how the 
nuclear Ca2+ transient is regulated in cardiomyocytes.
To understand the molecular mechanism of nuclear Ca2+ regulation, we focused on a specific molecule 
among the nuclear membrane proteins. We also focused on a genetic disease that is caused by a mutation in a 
nuclear membrane-associated gene and has a specific cardiac phenotype. Emerin (encoded by EMD) is ubiq-
uitously expressed and located in the inner nuclear membrane13. A mutation in EMD in humans is a cause of 
Emery-Dreifuss muscular dystrophy (EDMD) and results in a disorder of skeletal muscle and cardiac muscle 
including a cardiac conduction aberration and dilated cardiomyopathy (DCM)14–16. Emerin binds to several 
nuclear proteins and performs various functions in the nuclear lamina, nuclear structure, transcriptional regu-
lation, and chromatin architecture17–19. It is still largely uncertain how EDMD can be caused by the mutation in 
EMD. In particular, it is interesting how the mutation in the ubiquitous gene EMD causes a specific phenotype in 
heart and skeletal muscles. Ca2+ signaling is highly important for homeostasis within a contracting muscle, e.g., 
skeletal myocytes and cardiac myocytes. Disruption of Ca2+ signaling in cardiomyocytes results in cardiac hyper-
trophy and heart failure20,21. It remains unclear whether a nuclear membrane protein is involved in the regulation 
of the nuclear Ca2+ transient. Therefore, we hypothesized that emerin is involved in nuclear Ca2+ signaling in 
cardiomyocytes and participates in the pathogenesis of some cardiac diseases.
We analyzed nuclear structure and the nuclear Ca2+ transient in neonatal rat ventricular cardiomyocytes 
(NRVCs) after hypertrophic stimuli and in EDMD-induced pluripotent stem (iPS) cell-derived cardiomyocytes. 
The hypertrophic stimuli increased the nuclear area, decreased nuclear invagination, and increased the half-decay 
time of the nuclear Ca2+ transient in NRVCs. An Emd knockdown also increased the nuclear area, decreased 
the nuclear invagination, and increased the half-decay time of the nuclear Ca2+ transient without hypertrophic 
stimuli in NRVCs. Hypertrophic-stimulus-dependent changes in nuclear invagination and Ca2+ transients were 
attenuated by the Emd knockdown. The iPS cells were derived from a patient with EDMD and were induced to 
differentiate into cardiomyocytes. EDMD-iPS cell-derived cardiomyocytes also showed increased nuclear area, 
decreased nuclear invagination, and increased half-decay time of the nuclear Ca2+ transient. Furthermore, an 
autopsied heart from a patient with EDMD showed an increase in nuclear area and a decrease in nuclear invag-
ination. These data suggest that emerin has a crucial function in nuclear structure and in the nuclear Ca2+ tran-
sient in cardiomyocytes. Thus, emerin and the nuclear Ca2+ transient are possible therapeutic targets in heart 
failure and EDMD.
Results
Hypertrophic stimuli affect nuclear size and invagination in cardiomyocytes. Nuclear size and 
shape are important for cellular fine structure and function. Altered nuclear size and shape are associated with a 
wide variety of pathologies22,23. The number of nuclear envelop intrusions into the nuclear lumen (nuclear invag-
ination) in cardiomyocytes is decreased during cardiac remodeling12. To study the nuclear structure in cardio-
myocytes, we examined nuclear structure by immunofluorescence staining in NRVCs. We observed NRVCs with 
or without nuclear invagination in the basal condition (Fig. 1A, Supplementary Figure 1A,B). We also observed 
nuclear invagination by 3D reconstruction image and electron microscopy (Fig. 1B,C, Supplementary Figure 1C). 
The low-affinity Ca2+ indicator mag-fluo-4 can reveal the nuclear envelop and tubular invaginations that trav-
erse the nucleus, which imply that the nuclear envelop and its tubular invaginations are functional Ca2+ stores. 
MitoTracker Red specifically accumulated in both the subsarcomeric mitochondria (located around the nucleus) 
and in the intermyofibrillar mitochondria, and the fluorescence intensity of cardiomyocytes is known to be much 
stronger than that of nonmyocytes24. The mag-fluo-4 staining showed the nuclear invagination of the NRVCs in 
the basal condition (Fig. 1D). Next, we examined the effects of each hypertrophic stimulus on the nuclear size 
and shape in NRVCs. We used potent hypertrophic stimuli, such as angiotensin II (Ang II), endothelin 1 (ET-1), 
and phenylephrine (PE)25 (Fig. 1E, Supplementary Figure 1D). Given the prominent role of these cytokines as 
strong hypertrophy-promoting factors, we initially confirmed the cardiomyocyte hypertrophy by measuring the 
cell surface area (Supplementary Figure 1E), and then we examined the nuclei. The nuclear size was significantly 
increased by exposure to these hypertrophic stimuli (Fig. 1F, Supplementary Figure 1F,G). Nuclear invagination 
was defined as a nuclear intrusion consist of two membranes continuous with nuclear envelope observed by 
immunostaining for nuclear membrane proteins26,27, and nuclear tubular structures longer than 1 μ m12. In this 
study, we defined nuclear invaginations as tubular structures continuous with nuclear envelope longer than 1 μ m 
by immunostaining for nuclear membrane proteins. The incidence of cardiomyocytes with a nuclear invagination 
was significantly decreased by exposure to the hypertrophic stimuli (Fig. 1G, Supplementary Figure 1H).
Hypertrophic stimuli affect the nuclear Ca2+ transient. Although the cytosolic Ca2+ transient plays 
important roles in the pathogenesis of heart diseases, it is mostly unclear whether the nuclear Ca2+ transient 
in cardiomyocytes would be affected by various hypertrophic stimuli. To analyze the kinetics of nuclear and 
cytoplasmic Ca2+ transients, NRVCs were loaded with the Ca2+ indicator Fluo-4, which diffuses both to the cyto-
plasm and nucleus, and rapid resolution confocal microscopic analysis was then conducted28,29. Fluo-4 staining 
discriminated the area of the nucleus (Fig. 2A), and line scan imaging was performed both in the cytoplasm and 
nucleus within the same cardiomyocytes (Fig. 2B,C, Supplementary Figure 2A,B,C,D). We also used different 
type of Ca2+ indicator, Rhod4 which had different Kd from fluo4, and observed similar nuclear Ca2+ dynamics 
(Supplementary Figure 2E,F,G). Time to peak in cytoplasmic Ca2+ transient was significantly increased by hyper-
trophic stimuli (Fig. 2D), but time to peak in nuclear Ca2+ transient was not affected by these stimuli (Fig. 2F). 
Half-decay time of cytoplasmic Ca2+ transient was not affected by hypertrophic stimuli (Fig. 2E), but that of 
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Figure 1. Nuclear structure with hypertrophic stimuli in neonatal rat ventricular cardiomyocytes (NRVCs). 
(A) Confocal microscopic images of immunostaining for cTnT (red), LAMIN A/C (green), and nuclei (blue) in 
NRVCs. The scale bar is 5 μ m. Left: a cardiomyocyte without nuclear invagination. Right: a cardiomyocyte with 
nuclear invagination. (B) Confocal microscopic images of immunostaining for LAMIN A/C (green) with 3D 
reconstruction, in NRVCs. The scale bar is 5 μ m. Top: a cardiomyocyte without nuclear invagination. Bottom: a 
cardiomyocyte with nuclear invagination. (C) Electron microscopic images of NRVC. The scale bar is 2 μ m. Left: 
a cardiomyocyte without nuclear invagination. Right: a cardiomyocyte with nuclear invagination. Red arrow 
indicates nuclear invagination. (D) Confocal microscopic images of Mag-fluo-4 fluorescence (green), MitoTracker 
(red), and nuclei (blue). The scale bar is 5 μ m. (E) Representative confocal microscopic images of immunostaining 
for cTnT (red), LAMIN A/C (green), and nuclei (blue) in control NRVCs and NRVCs subjected to hypertrophic 
stimuli: Ang II, ET-1, or PE. The scale bar is 5 μ m. (F) Bar graphs showing nuclear size in NRVCs exposed to vehicle 
(control; n = 100), Ang II (n = 26), ET-1 (n = 108), or PE (n = 79) for 48 hours in culture. The data are mean ± SD. 
(G) Bar graphs showing the percentages of cardiomyocytes with nuclear invagination among NRVCs exposed to 
vehicle (control; n = 47), Ang II (n = 97), ET-1 (n = 40), or PE (n = 56) for 48 hours in culture. *P < 0.05 compared 
to the control. **P < 0.01 compared to the control. †P < 0.001 compared to the control.
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Figure 2. The nuclear Ca2+ transient in neonatal rat ventricular cardiomyocytes (NRVCs) subjected to 
hypertrophic stimuli. (A) Confocal microscopic images of Fluo-4 fluorescence (green) and nuclei (blue). 
The scale bar is 20 μ m. (B) Characterization of cytoplasmic and nuclear Ca2+ transients in NRVCs. Line scan 
imaging of cytoplasmic (Left) and nuclear (Right) Ca2+ transients in cardiomyocytes. (C) Original recordings 
of nuclear and cytoplasmic Ca2+ transients of control NRVC. (D,E) Average values of the effects of hypertrophic 
stimuli on time to peak and half-decay time in the cytoplasmic of NRVCs exposed to vehicle (control; n = 19), 
Ang II (n = 42), ET-1 (n = 21), or PE (n = 29). (F,G) Average values of the effects of hypertrophic stimuli on 
time to peak and half-decay time in the nuclei of NRVCs exposed to vehicle (control; n = 19), Ang II (n = 42), 
ET-1 (n = 21), or PE (n = 29). *P < 0.05 compared to the control. **P < 0.01 compared to the control. †P < 0.001 
compared to the control.
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nucleus was significantly increased by hypertrophic stimuli (Fig. 2G). F/F0 in cytoplasmic and nuclear Ca2+ tran-
sient was not uniformly affected by hypertrophic stimuli (Supplementary Figure 2H,I). These data indicate that 
the effect of hypertrophic stimuli on the nuclear Ca2+ transient is independent of the cytoplasmic Ca2+ transient.
Emerin is involved in nuclear structure and in the Ca2+ transient in neonatal rat ventricular 
cardiomyocytes. To examine the role of emerin in cardiomyocytes, the cellular and nuclear structures 
were studied by immunofluorescent staining and electron microscopy in NRVCs during an siRNA-mediated 
Emd knockdown (Fig. 3A,B,C). SiRNA against Emd in cardiomyocytes efficiently downregulated the expres-
sion of Emd (Supplementary Figure 3A). Although cell surface area was not changed by siRNA against Emd 
(Supplementary Figure 3B), the incidence of cardiomyocytes with nuclear invagination was significantly 
decreased (Fig. 3B), and the nuclear size was significantly increased by transfection with siRNA against Emd 
(Fig. 3C,D, Supplementary Figure 3C). These data suggest that emerin has a pivotal function in the maintenance 
of nuclear invagination and nuclear size. Nuclear structural changes are associated with altered nuclear Ca2+ reg-
ulation in cardiomyocytes12. Then, we analyzed the Ca2+ transient both in the cytoplasm and nucleus in NRVCs 
during the Emd knockdown (Supplementary Figure 3E, Fig. 3E). F/F0 and time to peak were not affected in 
cytoplasmic Ca2+ and nuclear Ca2+ by siRNA against Emd (Fig. 3F,G, Supplementary Figure 3F,G,H). Half-decay 
time of the cytoplasmic Ca2+ was not affected by siRNA against Emd (Supplementary Figure 3F,H) but that of 
the nuclear Ca2+ was significantly increased by siRNA for Emd (Fig. 3H, Supplementary Figure 3G). These data 
suggest that emerin plays a specific role in the nuclear Ca2+ transient, independently of the cytoplasmic Ca2+ 
transient.
Emerin is indispensable for the hypertrophic-stimulus-induced change in the nuclear Ca2+ 
transient in neonatal rat ventricular cardiomyocytes. To examine the relation between hypertrophic 
stimuli and emerin in cardiomyocytes, we used hypertrophic stimuli in cardiomyocytes with the Emd knock-
down. The cellular and nuclear structures were examined by immunofluorescent staining in NRVCs (Fig. 4A). 
The hypertrophic stimuli had no significant effect on the nuclear invagination and nuclear area under Emd 
knockdown (Fig. 4B,C, Supplementary Figure 4A). Ca2+ transients of the cytoplasm and nucleus were also 
examined. Time to peak in cytoplasmic Ca2+ transient was significantly increased by the hypertrophic stimuli 
(Supplementary Figure 4D), but that in nuclear Ca2+ transient was not affected by hypertrophic stimuli under 
Emd knockdown (Fig. 4D). Half-decay times of cytoplasmic and nuclear Ca2+ transients were not affected by 
hypertrophic stimuli under Emd knockdown (Supplementary Figure 4E, Fig. 4E). The increases by hypertrophic 
stimuli in time to peak of cytoplasmic Ca2+ transient under Emd knockdown (Supplementary Figure 4D) was 
similar with that without Emd knockdown (Fig. 2D). Although hypertrophic stimuli increase half-decay time of 
nuclear Ca2+ transient (Fig. 2G), hypertrophic stimuli did not affect half-decay time of nuclear Ca2+ transient 
under Emd knockdown (Fig. 4E). To examine whether emerin induces nuclear invagination, we examined the 
nuclear structure under overexpression of emerin in NRVCs (Supplementary Figure 4G,H). Nuclear invagination 
is significantly increased by emerin overexpression (Supplementary Figure 4I). These results suggest that emerin 
would play a role in nuclear membrane structure and affect the nuclear Ca2+ transient during exposure to hyper-
trophic stimuli, which would be because nuclear invagination has a critical role in the nuclear Ca2+ transient28,29.
Recapitulation of the cellular phenotype in EDMD-iPS cell-derived cardiomyocytes. We suc-
cessfully derived iPS cells from a patient with EDMD. As controls, we used iPS cells derived from healthy volun-
teers: previously characterized control iPS cell lines30–32. At first, we confirmed the mutation in EMD by direct 
sequencing of DNA from EDMD-iPS cells. Sequence analysis of EMD showed a c.1735 G > A mutation (Fig. 5A). 
One report indicated that this mutation results in a deficiency of emerin expression33. The generated EDMD-iPS 
cells and control iPS cells showed stem cell marker expression (Supplementary Figure 5A). Subsequently, cardio-
myocytes were produced from the iPS cells, and immunostaining revealed that these iPS cell-derived cardiomy-
ocytes expressed cardiomyocyte-specific markers: α -Actinin, HCN4, NKX2.5, and cardiac troponin T (cTnT), 
and showed normal cardiomyocyte cellular structure (Supplementary Figure 5B). In electron-microscopic 
images of beating cardiomyocytes, we could not find any morphometric aberrations in EDMD-iPS cell-derived 
cardiomyocytes (Supplementary Figure 5C). We also confirmed that EMERIN is not detected in EDMD-iPS 
cell-derived cardiomyocytes (Fig. 5B,C). Distribution of nuclear membrane protein, such as LAMIN A/C, SUN1 
and SYNE1, which also can be causal mutations in EDMD, were not changed by a deficiency of EMERIN (Fig. 5D, 
Supplementary Figure 5D,E). Next, we analyzed the morphological features of the nucleus and cytoplasm of 
iPS cell-derived cardiomyocytes. The nuclear area was significantly increased (Fig. 5E), and the incidence of 
cardiomyocytes with nuclear invagination was significantly decreased in EDMD-iPS cell-derived cardiomyo-
cytes (Fig. 5F). There were no significant differences in the cell surface area between control and EDMD-iPS 
cell-derived cardiomyocytes (Fig. 5G,H). These data suggest that EDMD-iPS cell-derived cardiomyocytes 
decreased nuclear invagination similar to that of NRVCs transfected with siRNA against EMD.
Emerin is indispensable for the nuclear Ca2+ transient in EDMD-iPS cell-derived cardiomyo-
cytes. Ca2+ transients of cytoplasm and nucleus were also examined in control and EDMD-iPS cell-derived 
cardiomyocytes (Fig. 6A,B). There were no significant differences in cytoplasmic Ca2+ transient and nuclear Ca2+ 
transient in F/F0 and time to peak between control and EDMD-iPS cell-derived cardiomyocytes (Fig. 6C,D,F,G). 
Half decay time of nuclear Ca2+ transient was increased in EDMD-iPS cell-derived cardiomyocytes, but there 
was no significant change in half-decay time of cytoplasmic Ca2+ transient (Fig. 6E,H). These data suggest 
that EDMD-iPS cell-derived cardiomyocytes have Ca2+ transient similar to that of NRVCs treated with siRNA 
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Figure 3. Nuclear structure and the nuclear Ca2+ transient in Emd knockdown neonatal rat ventricular 
cardiomyocytes (NRVCs). (A) Top: Confocal microscopic images of immunostaining for cTnT (red), LAMIN 
A/C (green) and nuclei (blue) in NRVCs with control scrambled siRNA (siScrambled, left) and siRNA 
against Emd (siEmd, right). Bottom: Electron microscopic images of NRVCs with control scrambled siRNA 
(siScrambled, left) and siRNA against Emd (siEmd, right). The scale bar is 5 μ m. Red arrow indicates nuclear 
invagination. (B) Bar graphs showing the percentages of cardiomyocytes with nuclear invagination in NRVCs 
exposed to siScrambled (n = 69) and siEmd (n = 62) for 48 hours in culture. The data are mean ± SE. (C) Bar 
graphs showing the percentages of cardiomyocytes with nuclear size in NRVCs exposed to siScrambled (n = 69) 
and siEmd (n = 62) for 48 hours in culture. The data are mean ± SD. (D) Bar graph showing nuclear volumes in 
NRVCs exposed to siScrambled (n = 95) or siEmd (n = 138). The data are mean ± SD. (E) Original recordings of 
the nuclear Ca2+ transient of NRVCs with siScrambled (n = 25) and siEmd (n = 29). (F,G,H) Average values of 
the effects of the Emd knockdown on F/F0, time to peak, and half-decay time in the nuclei of NRVCs. *P < 0.05 
compared to the control. **P < 0.01 compared to the control. †P < 0.001 compared to the control.
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against EMD and indicate that emerin performs a critical function in the nuclear Ca2+ transient in human 
cardiomyocytes.
Cardiac nuclear morphology is disrupted in the heart of a patient with EDMD. To study the 
diseased adult heart, we used an autopsied heart from a patient with EDMD (EDMD-heart). We performed 
immunostaining for LAMIN A/C to elucidate the nuclear morphology and immunostaining for cTnT to identify 
the cardiomyocytes (Fig. 7A). The nuclear area was significantly increased in the EDMD-heart (Fig. 7B). The 
incidence of cardiomyocytes with nuclear invagination was significantly decreased in the EDMD-heart (Fig. 7C). 
These data suggest that the heart from an adult patient with EDMD has nuclear structure similar to that of NRVCs 
treated with siRNA and of EDMD-iPS cell derived cardiomyocytes.
Discussion
Cytoplasmic Ca2+ has several physiological functions in cardiomyocytes. Cardiac contraction is finely regulated 
by cytoplasmic Ca2+: EC coupling. Depolarization of the plasma membrane in cardiomyocytes activates LTCC 
to open in order to increase Ca2+ influx into the cytoplasm, but intracellular Ca2+-dependent inactivation limits 
Ca2+ influx during an action potential34. This locally upregulated Ca2+ binds to the ryanodine receptor (RyR) 
in SR adjacent to the plasma membrane, and this event triggers a massive efflux of Ca2+ from the SR into the 
cytoplasm: Ca2+-induced Ca2+ release (CICR)1. During the relaxation of cardiomyocytes, Ca2+ is sequentially 
removed from the cytoplasm. It seems that cytoplasmic Ca2+ is synchronously changed in the whole cytoplasm, 
but cytoplasmic Ca2+ is finely and locally regulated with respect to each microcompartment within the cell.
The nuclear Ca2+ transient shows different kinetics from those of the cytoplasmic Ca2+ transient35 and has 
its own role in target gene expression, independent of cytoplasmic Ca2+ 36,37. The nuclear envelope (NE), which 
is continuous with the endoplasmic reticulum (ER), not only contributes to nuclear structure and insulation 
from the surrounding cytoplasm but also stores Ca2+ around the nucleus38. The NE generates Ca2+ signals inde-
pendently of cytoplasmic Ca2+ 39. The NE is composed of two membranes: the outer nuclear membrane (ONM), 
a structure continuous with ER, and the inner nuclear membrane (INM) exposed to the nuclear matrix. The 
ONM harbors SERCA2, which actively transports Ca2+ from the cytoplasm surrounding the nucleus into the 
NE40. There are also the NCX complex and inositol trisphosphate (IP3) receptor in the INM, which are thought 
to be responsible for Ca2+ homeostasis in the nucleoplasm28,29. Furthermore, nuclear Ca2+ is also controlled by 
several nuclear membrane proteins, such as RyRs and nicotinic acid adenine dinucleotide phosphate receptors 
(NAADPRs)41,42.
Figure 4. Nuclear structure and the nuclear Ca2+ transient in Emd knockdown neonatal rat ventricular 
cardiomyocytes (NRVCs) subjected to hypertrophic stimuli. (A) Confocal microscopic images of 
immunostaining for cTnT (red), LAMIN A/C (green), and nuclei (blue) in NRVCs treated with siRNA against 
Emd after exposure to vehicle (control; n = 62), Ang II (n = 47), ET-1 (n = 56), or PE (n = 55) for 48 hours 
in culture. The scale bar is 20 μ m. (B) Bar graphs showing the percentages of cardiomyocytes with nuclear 
invagination in NRVCs treated with siRNA against Emd after exposure to vehicle (control; n = 62), Ang II 
(n = 47), ET-1 (n = 56), or PE (n = 55) for 48 hours in culture. The data are mean ± SE. (C) Bar graphs showing 
nuclear size of cardiomyocytes with nuclear invagination in NRVCs treated with siRNA against Emd after 
exposure to vehicle (control; n = 62), Ang II (n = 47), ET-1 (n = 56), or PE (n = 55) for 48 hours in culture. The 
data are mean ± SD. (D,E) Average values of the effects of hypertrophic stimuli on time to peak and half-decay 
time in the nucleus of NRVCs treated with siRNA against Emd after exposure to vehicle (control; n = 29), Ang II 
(n = 25), ET-1 (n = 49), and PE (n = 24).
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Figure 5. Nuclear structure and the nuclear Ca2+ transient in EDMD-iPS cell-derived cardiomyocytes. 
(A) Sequence analysis of genomic EMD in control and EDMD-iPS cells. Single nucleotide substitution G to A 
at position 1735 of EMD. (B) Confocal microscopic images of immunostaining for α -Actinin (red), EMERIN 
(green), and nuclei (blue) in control and EDMD-iPS cell-derived cardiomyocytes. The scale bar is 20 μ m.  
(C) Western blotting for EMERIN, SYNE1, and GAPDH in control and EDMD-iPS cell-derived 
cardiomyocytes. (D) Confocal microscopic images of immunostaining for cTnT (red), LAMIN A/C (green), 
and nuclei (blue) in control and EDMD-iPS cell-derived cardiomyocytes. The scale bar is 5 μ m. (E) Bar graphs 
showing nuclear size in control (n = 94) and EDMD-iPS cell-derived cardiomyocytes (n = 50). The data are 
mean ± SD. (F) Bar graphs showing the percentages of cardiomyocytes with nuclear invagination in control 
(n = 94) and EDMD-iPS cell-derived cardiomyocytes (n = 50). The data are mean ± SE. (G) Bar graphs 
showing cell surface area in control (n = 94) and EDMD-iPS cell-derived cardiomyocytes (n = 50). The data are 
mean ± SD. (H) Bar graphs showing the ratio of cell surface area to nuclear area in control and EDMD-iPS cell-
derived cardiomyocytes. The data are mean ± SD. *P < 0.05 compared to the control. **P < 0.01 compared to 
the control. †P < 0.001 compared to the control.
www.nature.com/scientificreports/
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The cellular environment affects the nuclear envelop shape including nuclear invagination43. These nuclear 
structures participate in cellular functions including nuclear Ca2+ signaling44. Nuclear invagination is required 
Figure 6. The nuclear Ca2+ transient in EDMD-iPS cell-derived cardiomyocytes. (A) Original recordings 
of nuclear and cytoplasmic Ca2+ transients of control iPS cell-derived cardiomyocytes. (B) Original recordings 
of nuclear and cytosolic Ca2+ transient of EDMD-iPS cell-derived cardiomyocytes. (C,D,E) Average values 
of F/F0, time to peak, and half-decay time in the nuclear Ca2+ transient of control (n = 16) and EDMD-iPS 
cell-derived cardiomyocytes (n = 25). (F,G,H) Average values of F/F0, time to peak, and half-decay time in the 
cytoplasmic Ca2+ transient of control (n = 16) and EDMD-iPS cell-derived cardiomyocytes (n = 25). *P < 0.05 
compared to the control.
www.nature.com/scientificreports/
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for prompt Ca2+ pump back to cytoplasm12,45,46, like T tubule in cytoplasmic Ca2+. In cardiomyocytes, nuclear 
invagination is firstly changed during cardiac remodeling, which suggests that nuclear invagination may play a 
critical role in hypertrophic gene program activation and cardiac remodeling12. It is still unclear how nuclear 
invagination is regulated, what molecules are involved in the regulation of this process. EMERIN is a nuclear 
membrane protein and binds to SUN1, SUN2 and SYNE1, which connect cytoplasm to nucleus and play a role in 
nuclear fine structure19,47. The decrease in EMERIN would affect those protein interactions and structural main-
tenance of nuclear invagination. We observed the prolongation of half-decay time but not time to peak, which 
suggests that the decrease of EMERIN would cause the dysregulation of Ca2+ pump back function mediated by 
nuclear invagination, rather than the dysregulation of Ca2+ release mechanism such as IP3 receptors and RyRs. In 
our experiments, the decrease in nuclear invagination may disturb the prompt Ca2+ pump back and prolong the 
half-decay time. The intracellular Ca2+ dynamics activates several transcription factors and co-factors, such as 
HDAC5, NFAT and MEF2C, which induce cardiac hypertrophy46,48,49. Alteration of the nuclear Ca2+ transient is 
an early event in cardiac remodeling12. Before the change in cytoplasmic Ca2+ transient, alteration of the nuclear 
Ca2+ transient and HDAC5 activation were observed12. The decrease in the half-decay time of nuclear Ca2+ which 
we observed would indicate the increased nuclear Ca2+ for a prolonged time in diastolic phase. The increased 
nuclear Ca2+ would activate Ca2+ dependent-transcription factors and co-factors in nucleus.
Numerous proteins have been identified in the NE membrane, including both ubiquitous and potentially cell 
type-specific proteins50. Each NE membrane protein has a unique role in spatial control of the genome, cell cycle 
regulation, or cytoskeletal organization. The precise molecular functions of most NE membrane proteins remain 
elusive19. The mutations known to be responsible for human genetic diseases give us a key to decipher the molecu-
lar function and the related disease mechanism. EMD is ubiquitously expressed and encodes a nuclear membrane 
protein13,51, but the disease signs in EDMD are restricted to skeletal muscle and cardiac muscle; this situation 
suggests that emerin may have a specific role in skeletal muscle and cardiac muscle. Here, we reported for the 
first time that emerin plays a role in nuclear invagination and nuclear Ca2+ transient. EDMD is also caused by 
gene mutations in other nuclear-membrane-associated proteins, such as LMNA, SYNE1, SYNE2, SUN1, SUN2, 
and TMEM4352–55. Although it remains unclear how emerin regulates nuclear invagination, we can theorize that 
emerin regulates nuclear invagination in collaboration with the above-mentioned nuclear membrane proteins. 
Figure 7. Cardiac nuclear morphology in an autopsied heart of a patient with EDMD. (A) Confocal 
microscopic images of immunostaining for cTnT (red), emerin (green), and nuclei (blue) in control and 
EDMD-heart. The scale bar is 20 μ m. (B) Bar graphs showing nuclear size in control and EDMD-heart (n = 65). 
The data are mean ± SD. (C) Bar graphs showing the percentages of cardiomyocytes with nuclear invagination 
in control and EDMD-heart (n = 65). The data are mean ± SE. *P < 0.05 compared to the control.
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We showed that an EDMD patient’s cardiomyocytes have a defect in nuclear invagination, but it is still not clear 
whether human adult cardiomyocytes have a defect in nuclear Ca2+ transients and what happens next to the 
defect of the nuclear Ca2+ transient. These issues should be clarified in the future. We also observed the increase of 
nuclear size. Nuclear size is regulated by several mechanisms such as nucleocytoplasmic transport, nuclear struc-
tural components, and post-mitotic nuclear assembly56. Nuclear architecture directly affects chromatin organi-
zation and regulates gene expression. Some factors that structure and modify chromatin also influence nuclear 
morphology and size56. Nuclear size would also possibly affect chromatin organization and gene expression. 
Previous report showed that hypertrophic stimuli induced the increase of nuclear size57. We speculate that the 
change in nuclear size by hypertrophic stimuli might play a role in gene expression related to cardiac hypertrophy.
Human cardiomyocytes from patients with genetic disorders are an ideal tool for clinical research, but their 
use is limited in basic research. Most basic researches conduct studies using animal models for research into rele-
vant diseases. It should be noted that there are many differences between animals and humans, and some human 
diseases cannot be reproduced in animal models. Here, we used iPS cell-derived cardiomyocytes to elucidate 
the cellular pathophysiology of the patient with EDMD. Recent methodological and technological progress can 
help researchers to derive iPS cells from patients with genetic disorders, induce iPS cells to differentiate into car-
diomyocytes, and then to purify the cardiomyocytes58–64, but such studies still require much labor and funding. 
Patient-specific iPS cells have contributed to disease modeling and drug screening30–32,65. Nonetheless, research is 
still in progress on how to make iPS cell-derived cardiomyocytes mature like adult rod-shaped cardiomyocytes. 
Therefore, the studies involving patient-specific iPS cells cannot be applied to all genetic diseases.
In summary, nuclear invagination is attenuated and the nuclear Ca2+ transient is affected by hyper-
trophic stimuli in NRVCs. The nuclei of Emd knockdown NRVCs also show characteristics similar to those of 
hypertrophic-factor-stimulated cardiomyocytes, but cell size and the cytoplasmic Ca2+ transient are not affected 
by the Emd knockdown. Human EDMD-iPS cell-derived cardiomyocytes also show attenuated nuclear invagi-
nation and an altered nuclear Ca2+ transient. These data suggest that EDMD would be caused by disturbances of 
nuclear invagination and of the nuclear Ca2+ transient. Nuclear invagination and the nuclear Ca2+ transient may 
be therapeutic targets in EDMD and cardiac remodeling. In addition, emerin may be a molecular mediator of 
nuclear invagination and of the nuclear Ca2+ transient in the heart.
Methods
Rat cardiomyocyte culture. Primary cultures of NRVCs were prepared as described previously66. In brief, 
NRVCs from 1- to 2-day-old Sprague–Dawley rats (CREA, Japan) were killed by decapitation and the hearts were 
immediately excised and subjected to Percoll gradient centrifugation and differential plating to enrich the car-
diac myocyte population and to deplete nonmyocytes. Cardiomyocytes were cultured in a mixture of Dulbecco’s 
modified Eagle’s medium (DMEM) and M199 (Sigma-Aldrich) with 10% of horse serum (GIBCO) and antibi-
otic-antimycotic agents (GIBCO). All procedures in the present study conformed to the principles outlined in 
the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH 
Publication No. 85-23, revised 1996 and updated 2011) and were approved by the Institutional Animal Care and 
Use Committee of Keio University School of Medicine.
Ca2+ imaging. Cardiomyocytes were placed in 35-mm glass-bottom dishes and loaded with 5 μ M Fluo-4 
(Invitrogen) or Rhod4 (AAT bioquest) in Tyrode’s solution (pH 7.40, NaCl 135 mM, NaHPO4 0.33 mM, 
MgCl2∙6H20 0.53 mM, CaCl2∙2H20 1.8 mM, HEPES-NaOH 5 mM, Glucose 5.5 mM) for 30 min at 37 °C. A fur-
ther 30 min was allowed for deesterification. Ca2+ imaging was performed at room temperature by confocal 
microscopy. Ca2+ imaging was performed by confocal microscopy (LSM 5 DUO Carl Zeiss, Jena, Germany) using 
a ×40/0.75 NA. The pinhole was set to 1 Airy unit, resulting in optical-slice thickness of 1.0 μ m. The confocal 
plane was set to the middle (z-axis) of the nuclei. A 512-pixel scan line was positioned to include the nucleus, and 
scanning was performed every 2 ms (a total of 10,000 times for a 20-second recoding). Cardiomyocytes sponta-
neously beating and electrically stimulated at 0.25 Hz were analyzed for F/F0, time to peak, and half-decay time.
Drug testing. Angiotensin II (Sigma-Aldrich), endothelin 1 (Sigma-Aldrich), and phenylephrine 
(Sigma-Aldrich) were used for the drug assays.
Small interfering RNA (siRNA). Rat Emd siRNA (s129800) and scrambled siRNA (4390846) were pur-
chased from Life Technologies. SiRNA was diluted with OPTI-MEM (Invitrogen) to 20 nmol/L and added in 
the amount of 125 μ L to 7.5 μ L OPTI-MEM-containing LipofectamineRNAi Max (Invitrogen). After incubation 
for 10 min at room temperature, the siRNA-Lipofectamine mixture was added to NRVCs with subsequent incu-
bated for 24 hours at 37 °C without horse serum and antibiotic-antimycotic agents. The cells were transferred to 
a maintenance medium without the horse serum and antibiotic-antimycotic agents, and then 100 nmol/L ET-1, 
100 nmol/L Ang II, or 50 μ mol/L phenylephrine were added with subsequent incubation for 48 hours. The cells 
were then harvested for RNA analysis, immunofluorescence staining, and Ca2+ imaging.
Emerin overexpression in NRVC. pCAG-GFP-IRES-Emerin plasmid was constructed by emerin cDNA 
and pCAG-GFP (Addgene) plasmid. Each 2.5 μ g plasmid were diluted with 150 μ l OPTI-MEM (Invitrogen) and 
added in the amount of 125 μ L to 3.5 μ L OPTI-MEM-containing Lipofectamine3000 (Invitrogen). After incuba-
tion for 10 min at room temperature, the mixture was added to NRVCs with subsequent incubated for 48 hours 
at 37 °C without horse serum and antibiotic-antimycotic agents. The cells were transferred to a maintenance 
medium without the horse serum and antibiotic-antimycotic agents, and then 50 μ mol/L phenylephrine were 
added with subsequent incubation for 48 hours. The cells were then harvested for immunofluorescence staining.
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Quantitative reverse-transcription (RT) PCR. For quantitative RT-PCR assays, total RNA was extracted 
from NRVCs (after 4 days of culturing) by means of the TRIzol Reagent (Invitrogen). One microgram of total 
RNA was reverse-transcribed into cDNA with the ReverTra Ace® qPCR RT Master Mix with gDNA Remover 
(TOYOBO). Quantitative RT-PCR for emerin (EMD) and GAPDH genes was conducted by means of the Power 
SYBR® Green PCR Master Mix (Applied Biosystems). Quantitative RT-PCR for EMD and GAPDH was per-
formed with the primer set shown in the Supplementary Table on a ViiA™ 7 Real Time PCR System (Applied 
Biosystems), and the cycling conditions were as follows: 20 seconds at 95 °C, followed by 40 cycles of 1 second 
at 95 °C and 20 seconds at 62 °C. Cycle threshold was calculated under default settings by means of real-time 
sequence detection software (Applied Biosystems). The expression levels of EMD were normalized to those of 
GAPDH.
Western blotting. Proteins from self-beating embryoid bodies (EBs) were extracted with RIPA buffer 
(Nacalai Tesque, Japan). The proteins were loaded on Mini-PROTEAN TGX Gels (Bio-Rad, 4% to 15%) and 
then electrophoretically separated and transferred onto nitrocellulose blotting membranes (GE Healthcare). 
The primary antibodies were anti-emerin (Abcam), anti-SYNE1 (Millipore), and anti-GAPDH (Cell Signaling 
Technology). Protein expression was visualized with appropriate horseradish peroxidase-conjugated secondary 
antibodies (anti-mouse HRP 1:2000, anti-rabbit HRP 1:2000) and enhanced chemiluminescence (Amersham 
Biosciences, Piscataway, NJ, USA), and was detected using an LAS-3000 luminoimager (Fujifilm Techno 
Products, Ayase-shi, Kanagawa, Japan). Protein bands were quantified using the ImageJ software (NIH, Bethesda, 
MD, USA).
Immunofluorescence. Colonies of undifferentiated iPS cells plated on a layer of mouse embryonic fibro-
blasts (feeder cells), iPS cell-derived cardiomyocytes, or NRVCs plated on fibronectin-coated dishes were fixed 
with 4% paraformaldehyde (MUTO Pure Chemicals, Tokyo, Japan) for 30 min at 4 °C. After that, the cells were 
permeabilized with 1% Triton X-100 and blocked with ImmunoBlock (DS Pharma Biomedical, Osaka, Japan). 
The samples were incubated at 4 °C overnight with each of the following primary antibodies: anti-OCT3/4 
(Santa Cruz Biotechnology, CA, USA), anti-NANOG (Abcam, Camb, UK), anti-SSEA3 (Millipore, MA, USA), 
anti-SSEA4 (Millipore), anti-Tra1-81 (Millipore), anti-Tra1-60 (Millipore), anti-troponin T (Thermo Scientific, 
MA, USA), anti-α -actinin (Sigma-Aldrich), anti-NKX2.5 (Santa Cruz Biotechnology), anti-HCN4 (Abcam), 
anti-emerin (Abcam, Sanata Cruz Biotechnology), anti-LAMIN A/C (Santa Cruz Biotechnology), anti-SUN1 
(Abcam), anti-LBR(Abcam), anti-NPC(Abcam) and anti-SYNE1 (ATLAS). Preparations were incubated for 
1 hour at room temperature with the isotype-specific secondary antibodies: an Alexa Fluor 488-conjugated 
chicken anti-rabbit IgG antibody, Alexa Fluor 594-conjugated goat anti-mouse IgG antibody, Alexa Fluor 
488-conjugated goat anti-rat IgM antibody, Alexa Fluor 594-conjugated goat anti-mouse IgM antibody, Alexa 
Fluor 488-conjugated goat anti-mouse IgG antibody, Alexa Fluor 594-conjugated chicken anti-goat IgG anti-
body, Alexa Fluor 633-conjugated goat anti-mouse IgG antibody and an Alexa Fluor 555-conjugated goat 
anti-rabbit IgG antibody, which were all acquired from Invitrogen. Nuclei were counterstained with 50 ng/mL 
4′ ,6-diamidino-2-phenylindole (DAPI; Invitrogen) or 1 μ g/mL Hoechst 33258 (Lonza). Fluorescent signals were 
detected under a fluorescence laser microscope (BZ9000 Keyence, Osaka, Japan) with ×10/0.45 numerical apara-
ture (NA)or a confocal microscope with ×40/0.75 NA, ×63/1.2 NA or a ×63 × 3/1.2 NA oil-immersion objective 
(LSM 5 DUO Carl Zeiss, Jena, Germany).
Measurement nuclear and cytoplasmic size of cardiomyocytes and assessment of nuclear 
invagination. The cytoplasm area was assessed by means of troponin T-positive area obtained by confocal 
microscopy (LSM5 DUO at × 40 × /0.75 NA), and the nuclear area was assessed by means of the DAPI-positive 
area set to the middle of a visual field under the LSM5 DUO at × 63 × 3/1.2 NA oil-immersion objective. Analysis 
of individual cells was performed in a blinded experiment using the area calculating system of LSM510. We per-
formed three dimensional images with 0.35 μ m z-stack thickness to assess nuclear invagination. Nuclear volume 
was assessed with DAPI staining by the IMARIS software (Bitplane Company, Zurich, Switzerland). Nuclear 
invagination was assessed with LAMIN A/C or LBR as previously described26 and with mag fluo4 as previously 
described67. Nuclear invagination positivity was defined as intrusion of LAMIN A/C or LBR inside the nucleop-
lasm (longer than 1 μ m) on one slice and three dimensional images.
Patients’ consent. All subjects provided informed consent for blood testing for genetic aberrations asso-
ciated with EDMD. The Ethics Committee of Kanazawa University approved the isolation and use of patients’ 
and control somatic cells for iPS cell experiments (approval No. 1147), which were performed only after the 
patients and controls had provided written informed consent. Isolation and use of patients’ and control cells were 
approved by the Ethics Committee of Keio University (20-92-5) and were performed after written informed con-
sent was obtained. The study was performed conforming to the Declaration of Helsinki.
Preparation of human iPS cells. To study the role of emerin in human cardiomyocytes, we focused on 
the human disease that is associated with a mutation in EMD33. The mutation in EMD leads to X-linked EDMD. 
EDMD is characterized by muscle weakness, DCM, and cardiac conduction defects. Therefore, we planned 
to derive iPS cells from a patient with EDMD, differentiate them into cardiomyocytes, and characterize the 
EDMD-iPS cell-derived cardiomyocytes. The iPS cells were derived from T lymphocytes by means of a Sendai 
virus encoding OCT3/4, SOX2, KLF4, and MYC58,68. Briefly, peripheral blood mononuclear cells (PBMCs) were 
collected and transferred at 1.5 × 106/well to a fresh anti-CD3 antibody-coated 6-well plate, and incubated for an 
additional 24 hours. Then, solutions containing the Sendai virus vectors individually carrying each of OCT3/4, 
SOX2, KLF4, and MYC were added at multiplicity of infection (MOI) of 10. After 24 hours of infection, the 
medium was changed to a fresh KBM 502 medium (KOHJIN BIO, Saitama, Japan), and the cells were collected 
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and split at 5 × 104 cells into 10-cm plates preseeded with mouse embryonic fibroblasts. After additional 24 hours 
of incubation, the medium was changed to the hiPSC medium (described below) supplemented with 4 ng/mL 
basic fibroblast growth factor (bFGF). Approximately 20 to 30 days after the infection, iPS cell colonies appeared 
and were picked. Sendai virus vectors carrying the same four specific transcriptional factors (separately) were 
purchased from Life Technologies (CytoTune-iPS Reprogramming Kit).
Genome sequencing. All subjects provided informed consent for blood testing for genetic aberrations asso-
ciated with EDMD. DNA sequencing was used to confirm the presence of the relevant mutation in patient-derived 
iPS cells. Genomic DNA was isolated using the Gentra Puregene Cell Kit (Qiagen, Venlo, Netherland), and the 
region encoding the mutation was amplified by PCR. The PCR product was analyzed by electrophoresis in a 1% 
agarose gel and purified using a Wizard SV Gel and PCR Clean-Up System (Promega, WI, USA). The purified 
PCR product was sequenced with the original primers shown in the Supplementary Table.
Human iPS cell culture. Human iPS cells were maintained for several passages on irradiated mouse embry-
onic fibroblast feeder cells in the hiPSC culture medium: 80% of DMEM/F12 (Sigma-Aldrich, MO, USA), 20% 
of the Knockout Serum Replacement (Invitrogen, CA, USA), 4 ng/mL bFGF (WAKO, Osaka, Japan), 2 mmol/L 
L-glutamine (Invitrogen), 0.1 mmol/L nonessential amino acids (Sigma-Aldrich), 0.1 mmol/L 2-mercaptoethanol, 
50 U/mL penicillin, and 50 mg/mL streptomycin (Invitrogen). The hiPSC medium was changed every 2 days, and 
the cells were passaged using 1 mg/mL collagenase IV (Invitrogen) every 5–7 days. After several passages, these 
cell lines were cultured in the human iPS cell medium consisting of Repro Stem (Repro cell) and 50 U penicillin 
and 50 mg/mL streptomycin (Invitrogen).
In vitro cardiomyocyte differentiation. The iPSCs were harvested using 1 mg/mL collagenase IV, and 
transferred to ultra-low attachment plates (Corning, NY, USA) in the Repro stem medium supplemented with 10 ng/
mL BMP4 (Wako) and 5 μ mol/L blebbistatin (Sigma) from day 0 to day 1. The medium was changed to Stempro34 
(Gibco) supplemented with 50 μ g/mL ascorbic acid (Sigma), 2 mmol/L glutaMAX (Invitrogen), 10 ng/mL 
BMP4, and 25 ng/mL activin A from day 1 to day 3. On day 3, the medium was changed to Stempro34 sup-
plemented with 50 μ g/mL ascorbic acid and 2 mmol/L glutaMAX. On day 4.5, the medium was changed to 
Stempro34 supplemented with 50 μ g/mL ascorbic acid, 2 mmol/L glutaMAX, and 2.5 μ mol/L IWR-1 (Sigma). 
On day 8.5, the medium was changed to the differentiation medium consisting of α Minimum Essential Medium 
(Gibco) supplemented with 2 mmol/L L-glutamine (Invitrogen), 0.1 mmol/L nonessential amino acids (Sigma), 
0.1 mmol/L 2-mercaptoethanol, 50 U/mL penicillin, and 50 mg/mL streptomycin (Invitrogen), and 10% of fetal 
bovine serum (Gibco). The medium was replaced every second day or every third day. After 20 to 30 days of 
differentiation, self-contracting EBs were picked and placed into fresh ultra-low attachment plates (Corning). 
For immunohistochemical and Ca2+ imaging analyses, a single-cell suspension of cardiomyocytes (isolated 
from spontaneously contracting EBs) by means of 0.25% trypsin (Invitrogen), 1 mg/mL type IV collagenase 
(Invitrogen), and ADS buffer (116 mmol/L NaCl, mmol/L KCl 5.4, 1 mmol/L NaH2PO4, 0.8 mmol/L MgSO4, 
5.5 mmol/L glucose, 20 mmol/L HEPES, pH 7.35, adjusted with NaOH) for 30 min. at 37 °C. The cells were plated 
in fibronectin-coated dishes and incubated for 5 days in the presence of 20% FBS. To analyze the iPSC-derived 
cardiomyocytes, the mixtures of contracting EBs derived from two independent iPSC lines were used in each 
case.
Immunohistological fluorescence assays. Histological sections of the autopsied heart from an 
83-year-old patient with EDMD and a 78-year-old control patient were permeabilized with 1% Triton X-100 
after deparaffinization, and the antigens were activated with Histo VT one (Nacalai Tesque) at 90 °C for 40 min. 
After that, cardiomyocyte-containing tissue slices were blocked with ImmunoBlock (DS Pharma Biomedical) at 
4 °C overnight and were incubated at 4 °C overnight with each of the following primary antibodies: anti-LAMIN 
A/C (Santa Cruz Biotechnology) and anti-troponin T (Thermo Fisher Scientific, MA, USA). Preparations 
were incubated for 1 hour at room temperature with the isotype-specific secondary antibodies: an Alexa Fluor 
488-conjugated chicken anti-rabbit IgG antibody and Alexa Fluor 594-conjugated goat anti-mouse IgG antibody, 
both obtained from Invitrogen. Nuclei were counterstained with 50 ng/mL DAPI (Invitrogen). Fluorescent signals 
were detected using a fluorescence laser microscope (BZ9000 Keyence, Osaka, Japan) or by confocal microscopy 
with a ×40/1.2 NA or ×63 × 3/1.2 NA oil-immersion objective (LSM 5 DUO Carl Zeiss, Jena, Germany) just as 
during the measurement of the cardiomyocyte cytoplasmic and nuclear area.
Statistical analyses. Continuous data are presented as mean ± SD. The significance of differences between 
two means was evaluated by unpaired t tests. Fisher’s exact probability test was used for comparisons between 
groups. Comparisons between more than two groups involved analysis of variance (ANOVA) followed by 
Dunnett’s test. Categorical data are presented as mean ± SE and are compared by using Chi-squared test. All 
analyses were conducted in EZR69; P < 0.05 was assumed to denote statistical significance.
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